For the quarter ending 2026-03-31, SGHT has $109,702K in assets. $55,799K in debts. $84,962K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 84,962 | 91,965 | 92,373 | 101,500 |
| Accounts receivable, net of allowance for credit losses of 139 and 234 at march 31, 2026 and december 31, 2025, respectively | 10,595 | 9,745 | 9,744 | 9,614 |
| Inventory, net | 7,007 | 7,767 | 7,984 | 6,214 |
| Prepaid expenses and other current assets | 3,948 | 3,257 | 3,494 | 2,103 |
| Total current assets | 106,512 | 112,734 | 113,595 | 119,431 |
| Property and equipment, gross | 4,066 | 4,011 | 3,884 | - |
| Less accumulated depreciation | 2,448 | 2,401 | 2,339 | - |
| Property and equipment, net | 1,618 | 1,610 | 1,545 | 1,460 |
| Operating lease right-of-use assets | 1,202 | 438 | 568 | 694 |
| Other noncurrent assets | 370 | 518 | 548 | 386 |
| Total assets | 109,702 | 115,300 | 116,256 | 121,971 |
| Accounts payable | 1,486 | 1,343 | 1,742 | 2,076 |
| Accrued compensation | 3,691 | 6,074 | 6,192 | 5,227 |
| Accrued and other current liabilities | 9,189 | 3,610 | 3,897 | 4,633 |
| Short-term debt, net | 3,797 | - | - | - |
| Total current liabilities | 18,163 | 11,027 | 11,831 | 11,936 |
| Long-term debt, net | 36,736 | 40,300 | 40,069 | 39,821 |
| Other noncurrent liabilities | 900 | 31 | 66 | 202 |
| Total liabilities | 55,799 | 51,358 | 51,966 | 51,959 |
| Common stock, par value 0.001 per share 200,000,000 shares authorized 54,033,998 and 53,493,711 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 54 | 54 | 52 | 52 |
| Additional paid-in-capital | 451,552 | 448,611 | 444,799 | 442,352 |
| Accumulated deficit | -397,703 | -384,723 | -380,561 | -372,392 |
| Total stockholders' equity | 53,903 | 63,942 | 64,290 | 70,012 |
| Total liabilities and stockholders' equity | 109,702 | 115,300 | 116,256 | 121,971 |
Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT)